SCHOTT Pharma AG & Co KgaA banner

SCHOTT Pharma AG & Co KgaA
F:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
F:1SXP
Watchlist
Price: 14.02 EUR -1.13% Market Closed
Market Cap: €2.1B

Income Statement

Earnings Waterfall
SCHOTT Pharma AG & Co KgaA

Income Statement
SCHOTT Pharma AG & Co KgaA

Rotate your device to view
Income Statement
Currency: EUR
Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
3
0
0
0
8
0
0
0
0
Revenue
899
N/A
1 131
+26%
1 365
+21%
949
-31%
957
+1%
955
0%
973
+2%
976
+0%
986
+1%
Gross Profit
Cost of Revenue
(582)
(731)
(886)
(625)
(634)
(639)
(653)
(646)
(654)
Gross Profit
316
N/A
400
+26%
479
+20%
324
-32%
323
0%
315
-2%
320
+1%
329
+3%
332
+1%
Operating Income
Operating Expenses
(145)
(172)
(226)
(155)
(132)
(155)
(136)
(139)
(146)
Selling, General & Administrative
(126)
(154)
(185)
(126)
(125)
(126)
(127)
(128)
(129)
Research & Development
(27)
(33)
(40)
(27)
(24)
(25)
(25)
(27)
(28)
Other Operating Expenses
7
15
(1)
(3)
18
(5)
17
16
12
Operating Income
171
N/A
228
+33%
254
+11%
169
-33%
191
+12%
160
-16%
184
+15%
190
+3%
187
-2%
Pre-Tax Income
Interest Income Expense
17
11
12
5
(1)
5
4
2
9
Non-Reccuring Items
7
8
8
2
1
0
0
0
0
Total Other Income
(9)
(5)
(5)
(3)
(7)
(1)
(1)
(0)
(9)
Pre-Tax Income
186
N/A
241
+30%
268
+11%
174
-35%
184
+6%
164
-11%
188
+14%
192
+2%
188
-2%
Net Income
Tax Provision
(34)
(45)
(46)
(23)
(34)
(30)
(40)
(45)
(41)
Income from Continuing Operations
152
196
222
150
150
134
148
147
147
Income to Minority Interest
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
Net Income (Common)
152
N/A
196
+29%
221
+13%
150
-32%
150
0%
134
-11%
147
+10%
147
0%
146
0%
EPS (Diluted)
1.01
N/A
1.3
+29%
1.47
+13%
1
-32%
0.99
-1%
0.89
-10%
0.98
+10%
0.97
-1%
0.97
N/A